Keywords: roche, zenapax, gets, first, approval, transplants, hoffmann-la

Roche's Zenapax Gets First Approval For Transplants

Article | 17 December 1997

Print This

Hoffmann-La Roche has been given approval in the USA to market Zenapax(daclizumab), a humanized monoclonal antibody, in combination with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in